Dental Consensus on HSCT - Part II: Dental Care During HSCT

During the state of immune vulnerability in hematopoietic stem cell transplantation (HSCT), the patient has an increased risk of developing a vast number of complications, including severe problems in the oral cavity. These situations require professional oral care to act in the diagnosis and treatment of these conditions, as well as to develop prevention protocols to minimize patient's complications. Oral mucositis, opportunistic infections, bleeding, specific microbiota, taste, and salivary alterations are complications that can occur during HSCT and interfere with various aspects, such as pain control, oral intake, nutrition, bacteremia and sepsis, days of hospitalization and morbidity. Several guidelines have been published to address the role of professional oral care during the HSCT, we describe a consensus regarding these recommendations.

References

Or R, Aker M, Shapira M, Resnick I, Bitan M, Samuel S . Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. Springer Semin Immunopathol. 2004; 26(1-2):133-42. DOI: 10.1007/s00281-004-0169-z. View

Hong C, Gueiros L, Fulton J, Cheng K, Kandwal A, Galiti D . Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019; 27(10):3949-3967. DOI: 10.1007/s00520-019-04848-4. View

Hovan A, Williams P, Stevenson-Moore P, Wahlin Y, Ohrn K, Elting L . A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010; 18(8):1081-7. DOI: 10.1007/s00520-010-0902-1. View

Eduardo F, Bezinelli L, Carvalho D, Ferreira M, Gobbi M, Rosin F . Is Salivary Busulfan the Cause of Oral Mucositis and the Changes in Salivary Antioxidant Enzymes After Hematopoietic Cell Transplantation?. Ther Drug Monit. 2020; 42(4):565-571. DOI: 10.1097/FTD.0000000000000757. View

Roldan C, Nouri K, Chai T, Huh B . Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis. Pain Pract. 2017; 17(8):1115-1121. DOI: 10.1111/papr.12566. View

Aster R, Bougie D . Drug-induced immune thrombocytopenia. N Engl J Med. 2007; 357(6):580-7. DOI: 10.1056/NEJMra066469. View

Schubert M, Eduardo F, Guthrie K, Franquin J, Bensadoun R, Migliorati C . A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 2007; 15(10):1145-54. DOI: 10.1007/s00520-007-0238-7. View

van der Werf A, Rovithi M, Langius J, De van der Schueren M, Verheul H . Insight in taste alterations during treatment with protein kinase inhibitors. Eur J Cancer. 2017; 86:125-134. DOI: 10.1016/j.ejca.2017.09.006. View

Spindola Antunes H, de Azevedo A, da Silva Bouzas L, Adao C, Pinheiro C, Mayhe R . Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood. 2006; 109(5):2250-5. DOI: 10.1182/blood-2006-07-035022. View

10.

Gupta A, Epstein J, Cabay R . Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc. 2007; 73(1):77-83. View

11.

Cho S, Lee D, Kim H . Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy. Int J Mol Sci. 2019; 20(11). PMC: 6600658. DOI: 10.3390/ijms20112666. View

12.

Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y . Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation. PLoS Pathog. 2020; 16(3):e1008348. PMC: 7082065. DOI: 10.1371/journal.ppat.1008348. View

13.

Eduardo F, Bezinelli L, Gobbi M, Santos V, Maluf F, Correa L . Severe oral infection caused by Pseudomonas aeruginosa effectively treated with methylene blue-mediated photodynamic inactivation. Photodiagnosis Photodyn Ther. 2019; 26:284-286. DOI: 10.1016/j.pdpdt.2019.04.013. View

14.

Mikulska M, Del Bono V, Viscoli C . Bacterial infections in hematopoietic stem cell transplantation recipients. Curr Opin Hematol. 2014; 21(6):451-8. DOI: 10.1097/MOH.0000000000000088. View

15.

Laheij A, Raber-Durlacher J, Koppelmans R, Huysmans M, Potting C, van Leeuwen S . Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019; 9(1):16929. PMC: 6858439. DOI: 10.1038/s41598-019-53073-w. View

16.

Muro M, Soga Y, Higuchi T, Kataoka K, Ekuni D, Maeda Y . Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis. Folia Microbiol (Praha). 2018; 63(5):587-597. DOI: 10.1007/s12223-018-0596-1. View

17.

Khaw A, Logan R, Keefe D, Bartold M . Radiation-induced oral mucositis and periodontitis - proposal for an inter-relationship. Oral Dis. 2013; 20(3):e7-18. DOI: 10.1111/odi.12199. View

18.

Boer C, Correa M, Miranda E, De Souza C . Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2009; 45(4):705-11. DOI: 10.1038/bmt.2009.237. View

19.

Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A . The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019; 27(10):4023-4033. DOI: 10.1007/s00520-019-04893-z. View

20.

Valour F, Senechal A, Dupieux C, Karsenty J, Lustig S, Breton P . Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014; 7:183-97. PMC: 4094581. DOI: 10.2147/IDR.S39601. View